HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luca Giovanella Selected Research

Thyroid Neoplasms (Thyroid Cancer)

5/2024Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series.
4/2024Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer.
3/2024Theranostics of Thyroid Cancer.
8/2023Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer.
8/2023Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus.
6/2023BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category.
4/2023Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis.
4/2023Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients.
1/2023Add-on radioiodine during long-term BRAF/MEK inhibition in patients with RAI-refractory thyroid cancers: a reasonable option?
1/2023Long-term predictive value of highly sensitive thyroglobulin measurement.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luca Giovanella Research Topics

Disease

105Thyroid Neoplasms (Thyroid Cancer)
05/2024 - 05/2002
51Neoplasms (Cancer)
03/2024 - 01/2012
31Thyroid Nodule (Nodule, Thyroid)
02/2024 - 06/2010
17Neoplasm Metastasis (Metastasis)
03/2024 - 01/2005
13Prostatic Neoplasms (Prostate Cancer)
09/2023 - 01/2013
11Thyroid Diseases (Thyroid Disease)
12/2023 - 01/2012
9Hyperthyroidism
02/2024 - 01/2011
8Hypothyroidism
01/2023 - 10/2008
7Carcinoma (Carcinomatosis)
03/2024 - 08/2010
7Papillary Thyroid Cancer
02/2024 - 01/2005
6Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2024 - 05/2009
6medullary Thyroid cancer
03/2024 - 01/2014
6Lymphoma (Lymphomas)
02/2022 - 06/2014
5Thyroiditis
08/2023 - 04/2011
5COVID-19
02/2022 - 07/2020
4Thyrotoxicosis
12/2023 - 11/2019
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 10/2012
3Follicular Adenocarcinoma
01/2020 - 05/2010
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2018 - 06/2014
3Lung Neoplasms (Lung Cancer)
11/2015 - 03/2002
2Lymphatic Metastasis
02/2024 - 01/2018
2Disease Progression
04/2023 - 03/2015
2Adenoma (Adenomas)
06/2022 - 01/2021
2Infections
02/2022 - 01/2020
2Paraganglioma (Paragangliomas)
09/2021 - 05/2016
2Graves Disease (Basedow Disease)
06/2021 - 01/2017
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2020 - 01/2020
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2019 - 08/2010
2Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
01/2018 - 11/2009
2Sarcoma (Soft Tissue Sarcoma)
03/2015 - 10/2013
2Breast Neoplasms (Breast Cancer)
05/2008 - 03/2002
1Nasopharyngeal Carcinoma
03/2022
1Anaplastic Thyroid Carcinoma
03/2022

Drug/Important Bio-Agent (IBA)

48ThyroglobulinFDA Link
05/2024 - 05/2002
45Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2024 - 08/2007
20IodineIBA
01/2024 - 03/2008
17Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2024 - 01/2006
16Calcitonin (Calcitonin, Eel)FDA LinkGeneric
11/2021 - 05/2009
13Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2002
12RadiopharmaceuticalsIBA
06/2022 - 05/2008
10Thyroxine (Levothyroxine)FDA LinkGeneric
01/2023 - 01/2006
9ProcalcitoninIBA
11/2021 - 06/2010
8AntibodiesIBA
01/2023 - 01/2011
7Thyroid HormonesIBA
12/2023 - 01/2018
7Thyrotropin AlfaFDA LinkGeneric
04/2023 - 10/2007
7Choline (Choline Chloride)IBA
01/2020 - 01/2013
6AntigensIBA
03/2021 - 03/2002
5Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
06/2022 - 01/2007
5AutoantibodiesIBA
06/2021 - 10/2012
4Tumor Biomarkers (Tumor Markers)IBA
04/2024 - 01/2012
4Dihydroxyphenylalanine (Dopa)IBA
03/2024 - 01/2020
4Radioisotopes (Radionuclides)IBA
03/2022 - 01/2013
4Somatostatin Receptors (Somatostatin Receptor)IBA
09/2021 - 11/2015
3Tyrosine Kinase InhibitorsIBA
12/2023 - 09/2014
3Prostate-Specific Antigen (Semenogelase)IBA
09/2023 - 05/2014
3Iodine-123IBA
04/2023 - 08/2013
3RacivirIBA
01/2021 - 05/2010
3Fluorine-18IBA
01/2020 - 01/2012
3TabletsIBA
01/2020 - 01/2018
3fluoromethylcholineIBA
01/2019 - 03/2014
2Immune Checkpoint InhibitorsIBA
12/2023 - 03/2022
2Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2021
2IsotopesIBA
06/2022 - 08/2014
22-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
05/2022 - 02/2022
2Peptide Receptors (Peptide Receptor)IBA
03/2022 - 09/2021
2fluorocholineIBA
01/2022 - 01/2019
2Triiodothyronine (Liothyronine)FDA LinkGeneric
11/2021 - 01/2021
2Gallium-68IBA
09/2021 - 01/2020
2IodidesIBA
06/2021 - 11/2019
2Thyrotropin Receptors (Thyrotropin Receptor)IBA
06/2021 - 01/2017
2Antithyroid Agents (Antithyroid Drugs)IBA
06/2021 - 01/2020
23-Iodobenzylguanidine (Iobenguane)IBA
01/2020 - 01/2014
2Iodine-131IBA
11/2018 - 04/2013
2Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link
08/2013 - 04/2011
2Keratin-19 (Keratin 19)IBA
12/2012 - 03/2002
2antigen CYFRA21.1IBA
12/2012 - 03/2002
2Heterophile AntibodiesIBA
01/2009 - 10/2007
1Iodine IsotopesIBA
03/2024
1AntioxidantsIBA
08/2023
1dabrafenibIBA
01/2023
1trametinibIBA
01/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023
1Circulating MicroRNAIBA
11/2022
1MicroRNAs (MicroRNA)IBA
11/2022
1Complement System Proteins (Complement)IBA
06/2022
1NivolumabIBA
03/2022

Therapy/Procedure

53Therapeutics
02/2024 - 03/2002
17Thyroidectomy
04/2024 - 01/2005
8Precision Medicine
04/2024 - 03/2018
3Radiofrequency Ablation
02/2024 - 01/2019
3Radiotherapy
03/2022 - 01/2018
3Drug Therapy (Chemotherapy)
01/2020 - 10/2012
2Parathyroidectomy
06/2022 - 01/2021
2Operative Surgical Procedures
06/2022 - 08/2014
2Immunotherapy
03/2022 - 09/2020
2Extracorporeal Shockwave Therapy
01/2018 - 01/2018
1Castration
09/2023
1Aftercare (After-Treatment)
01/2023
1Microspheres (Microsphere)
01/2023
1Chemoradiotherapy
03/2022